Evidence map›Paper›PMID 29135604›Full record

ArticleCornea2018

Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities.

Claes H Dohlman, Fabiano Cade, Caio V Regatieri, Chengxin Zhou, Fengyang Lei, Alja Crnej, Mona Harissi-Dagher, Marie-Claude Robert, George N Papaliodis, Dongfeng Chen and 21 more

Open access · greenAbstract read
In one paragraph

Article in Cornea, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Intrinsic Optical Properties of Boston Keratoprosthesis.Translational vision science & technology · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Correlation analysis of the clinical features and prognosis of acute ocular burns-exploration of a new classification scheme.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020
    Article
  15. Article
  16. RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularization.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. Microglia Regulate Neuroglia Remodeling in Various Ocular and Retinal Injuries.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  18. Permanent neuroglial remodeling of the retina following infiltration of CSF1R inhibition-resistant peripheral monocytes.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 1 institution in 1 country.

Claes H DohlmanCornea Service and Boston Keratoprosthesis Laboratory, Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute, Harvard Medical School, Boston, MA.
Fabiano Cade
Caio V Regatieri
Chengxin Zhou
Fengyang Lei
Alja Crnej
Mona Harissi-Dagher
Marie-Claude Robert
George N Papaliodis
Dongfeng Chen
James V Aquavella
Esen K Akpek
Anthony J Aldave
Kimberly C Sippel
Donald J DʼAmico
Jan G Dohlman
Per Fagerholm
Liqiang Wang
Lucy Q Shen
Miguel González-Andrades
James Chodosh
Kenneth R Kenyon
C Stephen Foster
Roberto Pineda
Samir Melki
Kathryn A Colby
Joseph B Ciolino
Demetrios G Vavvas
Shigeru Kinoshita
Reza Dana
Eleftherios I Paschalis
Massachusetts Eye and Ear Infirmary · US

Funding

The Molecular Basis Underlying Optic Nerve Growth in Development and RegenerationR01EY025259 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI CHEN, DONG FENG · 2016 to 2020
$3.2M
Antibiotic eluting contact lenses for the treatment of bacterial keratitisR01EY026640 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI CIOLINO, JOSEPH B. · 2017 to 2020
$2.0M
NEI NIH HHS R01 EY025259NEI NIH HHS R01 EY026640
6 · The paper itself

Abstract

purposeTo propose a new treatment paradigm for chemical burns to the eye - in the acute and chronic phases.

methodsRecent laboratory and clinical data on the biology and treatment of chemical burns are analyzed.

resultsCorneal blindness from chemical burns can now be successfully treated with a keratoprosthesis, on immediate and intermediate bases. Long term outcomes, however, are hampered by early retinal damage causing glaucoma. New data suggest that rapid diffusion of inflammatory cytokines posteriorly (TNF-α, etc) can severely damage the ganglion cells. Prompt anti-TNF-α treatment is markedly neuroprotective. Long term profound reduction of the intraocular pressure is also vital.

conclusionA new regimen, in addition to standard treatment, for severe chemical burns is proposed. This involves tumor necrosis factor alpha (TNF-α) inhibition promptly after the accident (primarily for retinal neuroprotection), prophylactic maximal lowering of the intraocular pressure (starting immediately), and keratoprosthesis implantation in a later quiet state.

Indexed as

Anti-Inflammatory AgentsBurns, ChemicalCarbonic Anhydrase InhibitorsCytokinesHumansInfliximabKeratoplasty, PenetratingNeuroprotective AgentsRetinaRetinal DiseasesTumor Necrosis Factor-alphaAnti-Inflammatory AgentsCarbonic Anhydrase InhibitorsCytokinesInfliximabNeuroprotective AgentsTumor Necrosis Factor-alpha

Identifiers

PMID29135604
PMCPMC8728745
OpenAlexW2767332738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.